Programs that provide home visits to ensure that designated groups of people have access to the COVID-19 vaccine. The primary focus is on those who are unable to leave their homes without the help of others or medical equipment (such as crutches, a walker, or a wheelchair) or who have been instructed not to leave home due to concerns about their health or illness, but others who have been given priority may also be eligible. After assessment and screening for possible contraindications (even if it is the second dose) and prior to vaccination, the recipient and/or their caregiver receives an EUA (emergency use authorization) fact sheet and the opportunity to ask any questions or discuss concerns, before their informed consent is documented and the vaccine they received is recorded. The vaccine provider should stay with the person for 15 minutes following the injection, or 30 if they have a history of allergic reactions. Adverse reactions to the drug are reported to the Vaccine Adverse Event Reporting System (VAERS) as required.